Friday, July 27, 2012

TEVA - Adjustment

The following adjustment was made today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.

CriteriaValue
Dividend Champions StatusContender
Years of Consecutive Dividend Increases13
Fair Value Estimate$55.00
Target Buy Price$38.50
Target Margin of Safety30.00%
Actual Buy Price$40.00
Actual Margin of Safety27.27%

*Fair Value was lowered from $58 to $55 since inception which lowered my 31.03% Margin of Safety to 27.27%.

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
7/27/2012TEVAContinued TradeSTO 1 Sep12 45.00 Call @ 0.25  $25.24

Current Position Summary

Cost Basis($4,000.00)
Income Generated$95.48
Percent Income Generated2.39%
Annualized Income Generated4.76%
Net Profit If Assigned$595.48
Percent Return If Assigned14.89%
Annualized Return If Assigned29.69%
Days Held to Expiration183 days

Trade History

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
3/22/2012TEVACSP Margin UsedCSP 100 TEVA @ 40.00 ($4,000.00) 
3/22/2012TEVAInitial Put OptionSTO 1 May12 40.00 Put @ 0.51Exercised $50.97
5/18/2012TEVACSP Margin ReturnedCSP 100 TEVA @ -40.00 $4,000.00 
5/18/2012TEVAStock AssignedEX 1 May12 40.00 Put @ -40.00 ($4,000.00) 
6/25/2012TEVAContinued TradeSTO 1 Jul12 42.50 Call @ 0.19Expired $19.27
7/27/2012TEVAContinued TradeSTO 1 Sep12 45.00 Call @ 0.25  $25.24
9/21/2012TEVA Totals ($4,000.00)$95.48
DTE183 Percent Income/Annualized 2.39%4.76%